Strati Sakellariou-Witt

Partner, White & Case LLP

Strati Sakellariou-Witt advises on European competition law and general European Union law questions. She has particular expertise in pharmaceuticals and life sciences, advising on competition law issues, including distribution, rebates, generic and biosimilar entry. Strati also advises pharmaceutical, biotech and life sciences multinationals on EU and national law and policy affecting the pharmaceuticals and veterinary medicines sector, including licensing and distribution issues, complex regulatory matters, intellectual property and national implementation of EU measures. Strati successfully represented Pfizer and Abbott in abuse of dominance court proceedings in relation to parallel trade of pharma­ceuticals. She also represents clients in merger control reviews, and has comprehensive experience in in-depth investigations, which include negotiation of divestitures. Recently, she represented Zimmer Holdings, a world leader in musculoskeletal health solutions, in obtaining merger clearance from the European Commission for its US$13.35 billion acquisition of Biomet, Inc. This complex Phase II case was cleared two months prior to the official deadline.